Menu

Industry

Healthcare & Pharmaceuticals

Capital for the institutions that care and the companies that supply them.

Hospitals, diagnostics chains, pharmaceutical manufacturers and healthcare suppliers all need capital, but for different reasons and over different horizons. We structure funding to fit equipment cycles, regulatory timelines and the working-capital demands of the sector.

Funding needs

Healthcare & Pharmaceuticals businesses typically need

Hospital and clinic build-out

Land, construction, fit-out and ramp-up funding for new facilities.

Medical equipment and technology

Financing for diagnostic, surgical and imaging equipment with long useful lives.

Pharma manufacturing capacity

Plant expansion, upgrades and compliance-driven capital expenditure.

Working capital and distribution

Funding the gap between supplying hospitals and distributors and getting paid.

Structures

Funding structures we arrange

Equipment and asset finance

Facilities matched to the useful life of the equipment being funded.

Term loans for expansion

Longer-tenor debt for new facilities, plants and capacity additions.

Working-capital lines

Receivable and inventory-backed facilities for suppliers and manufacturers.

Growth equity and strategic investment

Capital from AIFs and international investors for platforms with consolidation or scale plans.

How we deal

How we deal with Healthcare & Pharmaceuticals

01

Understand the operating model

Capacity, utilisation, payer or customer mix and regulatory approvals.

02

Match funding to asset life

Long-life assets get long-tenor funding; working capital gets revolving lines.

03

Prepare diligence materials

Licences, approvals, utilisation data and historical financials, organised in advance.

04

Approach and negotiate

We take the case to the counterparties best suited to healthcare and manage terms.

An honest view

When funding makes sense, and when to wait.

Best suited when

Licences and regulatory approvals are current and clean
Utilisation or order books show a stable or improving trend
The expansion plan has a clear ramp-up assumption
Management and clinical or technical leadership are established

Less suited when

Regulatory approvals are pending with no clear timeline
Revenue is concentrated in one payer or one customer
The plan relies on assumptions that cannot be tested

Preparation

What lenders and investors look at in Healthcare & Pharmaceuticals.

We prepare your case against these points before it reaches a counterparty, so questions are answered early rather than late.

  • Licences, approvals and the compliance record
  • Utilisation, occupancy or order-book trends
  • Customer and payer concentration
  • Quality and continuity of management
  • Capex plan, ramp-up assumptions and repayment capacity

Explore further

Funding sources commonly used in healthcare and pharmaceuticals

Banks NBFCs AIFs Institutional Funding FDI Family Offices Private Investors

Questions

Common questions

Do you fund new hospitals?

We structure funding for new facilities, usually combining project debt with promoter equity or investor capital. The mix depends on the stage and track record.

Can foreign investors invest in Indian healthcare companies?

Foreign investment is possible, subject to sectoral rules that differ between segments such as hospitals, pharmaceuticals and medical devices. We guide you on the applicable route.

Is working-capital funding available for pharma distributors?

Yes, receivable and inventory-based facilities are common. The structure depends on your customer mix and payment cycles.

Tell us what you are building. We will help you fund it.

Request Appointment